B. SEVER Et Al. , "In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors," MOLECULES , vol.25, no.21, 2020
SEVER, B. Et Al. 2020. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. MOLECULES , vol.25, no.21 .
SEVER, B., ALTINTOP, M. D., ÖZDEMİR, A., AKALIN ÇİFTÇİ, G., Ellakwa, D. E., Tateishi, H., ... Radwan, M. O.(2020). In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. MOLECULES , vol.25, no.21.
SEVER, BELGİN Et Al. "In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors," MOLECULES , vol.25, no.21, 2020
SEVER, BELGİN Et Al. "In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors." MOLECULES , vol.25, no.21, 2020
SEVER, B. Et Al. (2020) . "In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors." MOLECULES , vol.25, no.21.
@article{article, author={BELGİN SEVER Et Al. }, title={In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors}, journal={MOLECULES}, year=2020}